Gene · 5144
Papers2,257
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,257
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PDE4D inhibitors: Opening a new era of PET diagnostics for Alzheimer's disease. | Neurochem Int | 2025 | 39647702 | PubTator, text mining | PubMed |
| Nanodomain cAMP signaling in cardiac pathophysiology: potential for developing targeted therapeutic interventions. | Physiol Rev | 2025 | 39115424 | PubTator, text mining | PubMed |
| Phosphodiesterase 9 localization in cytoplasm and nucleus: the gateway to selective targeting in neuroprotection? | Neural Regen Res | 2025 | 39104101 | PubTator, text mining | PubMed |
| 3D-QSAR Studies on High-affinity Phosphodiestera. | Curr Med Chem | 2025 | 38231072 | PubTator, text mining | PubMed |
Depletion of intrinsic renal macrophages with moderate-to-high expression of CD163, MRC1, PTH2R, PDE4D, and CUBN in regulating podocyte injury in diabetic nephropathy: a single-cell RNA sequencing analysis. | Transl Androl Urol | 2024 | 39698573 | PubTator, text mining | PubMed |
| PDE4D drives rewiring of the MAPK pathway in BRAF-mutated melanoma resistant to MAPK inhibitors. | Cell Commun Signal | 2024 | 39574163 | PubTator, text mining | PubMed |
| Utilizing an integrated bioinformatics and machine learning approach to uncover biomarkers linking ulcerative colitis to purine metabolism-related genes. | Heliyon | 2024 | 39524758 | PubTator, text mining | PubMed |
| Genomic variations associated with risk and protection against vincristine-induced peripheral neuropathy in pediatric cancer patients. | NPJ Genom Med | 2024 | 39500896 | PubTator, text mining | PubMed |
| Auditory N1 event-related potential amplitude is predictive of serum concentration of BPN14770 in fragile X syndrome. | Mol Autism | 2024 | 39488698 | PubTator, text mining | PubMed |
| Rationale design and synthesis of new roflumilast analogues as preferential selective and potent PDE-4B inhibitors. | Bioorg Chem | 2024 | 39467506 | PubTator, text mining | PubMed |
| The evolutive role of shoot apical meristems in the adaptation of angiosperms to life at sea and the jump to potential environmental biotechnology applications. | Sci Total Environ | 2024 | 39419216 | PubTator, text mining | PubMed |
| Development of selective heterocyclic PDE4 inhibitors for treatment of psoriasis. | Eur J Med Chem | 2024 | 39383652 | PubTator, text mining | PubMed |
| Expression Pattern of PDE4B, PDE4D, and SFRP5 Markers in Colorectal Cancer. | Medicina (Kaunas) | 2024 | 39202484 | PubTator, text mining | PubMed |
| Predicting novel targets with Bayesian machine learning by integrating multiple biological signatures. | Chem Sci | 2024 | 39170720 | PubTator, text mining | PubMed |
| PDE4D: A Multipurpose Pharmacological Target. | Int J Mol Sci | 2024 | 39125619 | PubTator, text mining | PubMed |
| Genetic polymorphisms to identify patients with an optimal response to tildrakizumab in psoriasis patients from real-life clinical practice. | Exp Dermatol | 2024 | 39081053 | PubTator, text mining | PubMed |
| Phosphodiesterase 4D activity in acrodysostosis-associated neural pathology: too much or too little? | Brain Commun | 2024 | 38983619 | PubTator, text mining | PubMed |
| Targeting LINC00152 activates cAMP/Ca2+/ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer. | Cell Death Dis | 2024 | 38879508 | PubTator, text mining | PubMed |
| Discovery of 7-alkoxybenzofurans as PDE4 inhibitors with hepatoprotective activity in D-GalN/LPS-induced hepatic sepsis. | Eur J Med Chem | 2024 | 38861808 | PubTator, text mining | PubMed |
| Differential Downregulation of β1-Adrenergic Receptor Signaling in the Heart. | J Am Heart Assoc | 2024 | 38860414 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5144/papers?page=6